Saturday, March 03, 2007

The State of the Art of Treatment for Pediatric and Adolescent ADHD



Medscape News - After controlling for such differences in study design, the average effect size of nonstimulant/other medication (0.62 explored atomoxetine treatment for children aged 8 to 17 years who met criteria for both ADHD and either generalized anxiety
Source: www.medscape.com

Drug Approval
HealthCentral.com - benzodiazepine drug alprazolam (Xanax), and better than placebo, in treating mental and physical symptoms of generalized anxiety Journal of the American Medical Association , patients responded best to this combination of psychotherapy and medication
Source: www.healthcentral.com


Click here for more information about what is anxiety